11 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Inhibitor Therapeutics Competitors or Alternatives

Inhibitor Therapeutics's top competitors include Innate Pharma, GENVEC and Transgene.

Unlock 13 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Inhibitor Therapeutics's company profile

Nicholas Virca

President & CEO

69/100
8
$5.5M
$ < 1M
  • $5.5M
    $ < 1M
  • 8
    $5.5M
  • $ < 1M
  • 69/100
  • 8
  • $5.5M
  • $ < 1M
View ProfileView
1
Inhibitor Therapeutics's Competitor - Innate Pharma logo

Jonathan Dickinson

Chairman & CEO

82/100
179
$191M
$37.5M
  • $191M
    $37.5M
  • 179
    $191M
  • $37.5M
  • 82/100
  • 179
  • $191M
  • $37.5M
View ProfileView
2
Inhibitor Therapeutics's Competitor - GENVEC logo

Douglas J. Swirsky

President & CEO

67/100
25 - 100
$64M
$100K - 5M
  • $64M
    $100K - 5M
  • 25 - 100
    $64M
  • $100K - 5M
  • 67/100
  • 25 - 100
  • $64M
  • $100K - 5M
View ProfileView
3
Inhibitor Therapeutics's Competitor - Transgene logo

Alessandro Riva

Chairman & CEO

82/100
168
$183.4M
$10.3M
  • $183.4M
    $10.3M
  • 168
    $183.4M
  • $10.3M
  • 82/100
  • 168
  • $183.4M
  • $10.3M
View ProfileView
4
Inhibitor Therapeutics's Competitor - Selecta logo

CEO

- -
25 - 100
$555.8M
$25M - 100M
  • $555.8M
    $25M - 100M
  • 25 - 100
    $555.8M
  • $25M - 100M
  • - -
  • 25 - 100
  • $555.8M
  • $25M - 100M
View ProfileView
5
Inhibitor Therapeutics's Competitor - Cellectis logo

Andre Choulika

CEO

89/100
222
$1B
$25.7M
  • $1B
    $25.7M
  • 222
    $1B
  • $25.7M
  • 89/100
  • 222
  • $1B
  • $25.7M
View ProfileView
Inhibitor Therapeutics' top 16 competitors are Innate Pharma, GENVEC, Transgene, bluebird bio, Selecta, Cellectis, Mablink, Theravectys, Spark Therapeutics, Domain Therapeutics, Verastem Oncology, Alnylam, TxCell, Trophos, Gadeta and Agenus. Together they have raised over 10.2B between their estimated 4.8K employees. Inhibitor Therapeutics has 8 employees and is ranked 17th among it's top 10 competitors. The top 10 competitors average 280.

Inhibitor Therapeutics VS Innate Pharma

Innate Pharma is Inhibitor Therapeutics's top competitor. Innate Pharma is a Public company that was founded in Marseille, Provence-Alpes-Côte-d'Azur in 1999. Innate Pharma operates in the Biotechnology industry. Innate Pharma has 171 more employees vs. Inhibitor Therapeutics.

Inhibitor Therapeutics VS GENVEC

GENVEC has been one of Inhibitor Therapeutics's top competitors. GENVEC is headquartered in Gaithersburg, Maryland, and was founded in 1992. GENVEC is in the Pharmaceuticals field. GENVEC generates ∞% the revenue of Inhibitor Therapeutics.

Inhibitor Therapeutics VS Transgene

Transgene is perceived as one of Inhibitor Therapeutics's biggest rivals. Transgene was founded in 1979 in Strasbourg, Other. Transgene competes in the Biotechnology field. Transgene generates $10.3M more revenue than Inhibitor Therapeutics.

Looking for similar companies to Inhibitor Therapeutics?

Similar Companies

Companies in null with employees in 1-25 range

See 19 companies 
Pharmaceuticals companies in Florida

See 557 companies 
Pharmaceuticals companies with employees in 1-25 range

See 2,177 companies 
Pharmaceuticals & Biotechnology companies in Florida

See 980 companies 
Pharmaceuticals & Biotechnology companies with employees in 1-25 range

See 4,705 companies 
Pharmaceuticals companies in USA

See 8,302 companies 
Pharmaceuticals companies in North America

See 9,691 companies 
Pharmaceuticals & Biotechnology companies in USA

See 18,427 companies 
Companies in Florida with employees in 1-25 range

See 19,640 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Inhibitor Therapeutics and Inhibitor Therapeutics's Competitors

July 13, 2026Pulse2.0
Agenus announced that it entered into a securities purchase agreement for an oversubscribed private placement of approximately $85 million in upfront g...
July 14, 2026Nasdaq
Key PointsThe president of Arcus Biosciences sold 68,569 shares for $2.0 million during the July 9 and July 10 trading sessions....
July 14, 2026Benzinga
Agenus Inc. (AGEN) stock experiences profit-taking on Tuesday after a 111% surge. Discover the latest clinical data and analyst updates.read more...

Frequently Asked Questions about Inhibitor Therapeutics

  1. Who are Inhibitor Therapeutics's top competitors?

    Inhibitor Therapeutics's top 3 competitors are Innate Pharma, GENVEC, Transgene.

  2. Who is similar to Inhibitor Therapeutics?

    Innate Pharma is the most similar to Inhibitor Therapeutics. GENVEC and Transgene are also similar to Inhibitor Therapeutics.

  1. Are Inhibitor Therapeutics and Innate Pharma competitors?

    Yes, Innate Pharma is one of Inhibitor Therapeutics’s top competitors.